Recently, dental lasers' manufacturer and distributor,
) was awarded a new patent for its non-contact laser hand piece
for tissue cutting by the U.S. Patent and Trademark Office, which
further strengthened its position in the laser dentistry
The patent titled "Non-Contact Handpiece for Laser Tissue" is
for Biolase's non-contact hand piece for cutting both hard and
soft tissue using its WaterLase all tissue lasers.
According to the company, the non-contact laser hand piece is
designed to provide high-density uniform laser beam from a
particular distance to the target tissue. Owing to this feature
of the product, back reflections and inefficiency can be reduced
while operating on the tissues. The company further believes that
they have an edge over its competitors since non-contact laser
handpiece is user-replaceable and can be configured according to
the optimal operational distance and focal spot sizes.
The new patent comes on the heels of FDA clearance for
Biolase's EPIC 10S soft tissue diode laser issued earlier this
BIOLASE develops and markets lasers and related products for
applications in medicine and dentistry. Its key products, the
dental laser systems, perform a broad spectrum of dental
procedures, including cosmetic and complex surgical applications.
To date the company has worked with over 340 patents and patent
pending technologies made to deliver efficient performance with
speed, less pain and more efficiency. To date, the company has
sold more than 22,000 lasers.
Currently, Biolase carries a Zacks Rank #3 (Hold). Other
medical and laser instrument stocks worth considering are
GSI Group Inc.
). While Cepheid carries a Zacks Rank #1 (Buy), GSI Group and
Cynosure carry a Zacks Rank #2 (Buy).
BIOLASE TECH (BIOL): Free Stock Analysis
CEPHEID INC (CPHD): Free Stock Analysis
CYNOSURE INC-A (CYNO): Free Stock Analysis
GSI GROUP INC (GSIG): Free Stock Analysis
To read this article on Zacks.com click here.